Corona: What measures have Governments taken in the Life Sciences Sector?
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
Governments have been implementing different emergency measures in the fight against the current pandemic. The Baker McKenzie Healthcare and Life Sciences Industry Group has now published an interesting overview of the different measures that various governments across the EMEA region (Europe, Middle East, Asia) have adopted in the area of healthcare and life sciences in response to the COVID-19 outbreak.
In this document, Baker McKenzie lawyers across EMEA share their high-level views on the following areas:
- Requisition powers
- Price and reimbursement
- Public procurement
- Legal deadlines
- Relaxation of regulatory rules
Related GMP News
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan
19.08.2026FDA: Simplified Registration for U.S. Sites and Greater Complexity for Non-U.S. Sites
12.08.2026When Training Fails: FDA Warning Letters Highlight GMP Training Deficiencies in 2026
29.07.2026EU-GMP for Veterinary Medicinal Products: What will change in Switzerland?